Martin J. Auger

759 citations
17 papers · 470 indexed · h-index 10
Topics
Multiple Myeloma Research and Treatments (6 papers)Chronic Lymphocytic Leukemia Research (5 papers)Acute Myeloid Leukemia Research (3 papers)

In The Last Decade

Martin J. Auger

17 papers receiving 461 citations

Peers

Martin J. Auger
Comparison fields: 5 of 63
  • Hematology 213
  • Molecular Biology 200
  • Oncology 103
  • Immunology 77
  • Genetics 72
Replace Chul‐Soo Cho with:
Chul‐Soo Cho South Korea
Marlyse A. Debrincat Australia
Gretchen LaRusch United States
Petra Goldin-Lang Germany
José María Bastida Spain
Marion Lebois Australia
Miriam Koch Germany
Toshiaki Shirai Japan
Darren Evanchuk United States
M J Jorgensen United States
Martin J. Auger relative to Chul‐Soo Cho South Korea Chul‐Soo Cho's profile →
Citations per field
00.5×1.5×2.2×
Chul‐Soo Cho · 1×
Citations per year

Countries citing papers authored by Martin J. Auger

Since Specialization
Citations

This map shows the geographic impact of Martin J. Auger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. Auger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. Auger more than expected).

Fields of papers citing papers by Martin J. Auger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. Auger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. Auger. The network helps show where Martin J. Auger may publish in the future.

Co-authorship network of co-authors of Martin J. Auger

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. Auger. A scholar is included among the top collaborators of Martin J. Auger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. Auger. Martin J. Auger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 165
2 23
3 2
4 40
5 48
6 2
7 6
8 22
9 23
10 7
11 37
12 6
13 21
14 7
15 21
16 2
17 38

About Martin J. Auger

Martin J. Auger is a scholar working on Hematology, Genetics and Internal Medicine, having authored 17 papers that have together received 470 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (213 citations), Genetics (72 citations) and Internal Medicine (18 citations). Martin J. Auger has collaborated with scholars based in United Kingdom, Australia and Hungary. Frequent co-authors include M.J. Mackie, Kristian M. Bowles, Stuart A. Rushworth, Lyubov Zaitseva, Megan Y. Murray, Rachel E. Piddock, Zhigang Zhou, Christopher R. Marlein, Rebecca H. Horton and Charlotte Hellmich. Their work appears in journals such as Blood, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026